We are delighted to announce that we have completed the first clinical trial of patientMpower for kidney dialysis. The study (NCT03403491), which was conducted in conjunction with Professor Conall O’Seaghdha and his team at Beaumont Hospital in Dublin, compared the use of patientMpower to usual care in patients undergoing kidney dialysis.
We are delighted to have recently started a new trial with the patientMpower platform for renal dialysis. Together with researchers in Beaumont Hospital, Dublin, Ireland, we are examining how the patientMpower app can help people undergoing renal dialysis to better manage their fluid weight gain between dialysis sessions. The trial protocol is available on clinicaltrials.gov.
The devastation and loss of life caused by the wildfires in California this month has been horrifying and upsetting. As well as the terrible destruction at the sites of the wildfires, the resulting impact on air quality has had serious health implications for people hundreds of miles away from the fires themselves. At one point, the air quality in San Francisco was rated the world’s worst as smoke and particles from the fires filled the air.
patientMpower attended the International Congress on Lung Transplantation. It brought together a fantastic range of pulmonologists, nurses, scientists and other professionals from all over the world working to improve outcomes in Lung Transplantation. The topics covered were many and varied, so here we’ve condensed a few takeaways for people considering a lung transplant.
For the latest in our video chats for Pulmonary Fibrosis awareness month, we’re joined by Angela Perillo from the American College of CHEST physicians. Angela talks through different educational activities which CHEST organizes to raise PF awareness, including next month’s annual CHEST meeting in San Antonio Texas.
September is a global month long campaign to help raise awareness of Pulmonary Fibrosis, aid timely diagnosis and help patients with pulmonary fibrosis to get the treatment and care that they need. This is our second Pulmonary Fibrosis chat of the month – & we’re delighted to be joined by Emmy award winner Mike Olsen.
September is a global month long campaign to help raise awareness of Pulmonary Fibrosis, aid timely diagnosis and help patients with pulmonary fibrosis to get the treatment and care that they need. At patientMpower we will be involved in lots of activities for Pulmonary Fibrosis month – This video is the first in our video series for the month. We’re delighted to be joined by Michele Peters from Team Jeffery for PF for our first video of the month.
We are delighted that our app for IPF has been recently been endorsed by the EU-IPFF. The European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF) is a non-profit organization that brings together European national patient associations committed to defending their vision of equal access to treatment and care for all IPF patients. They aim to serve as a trusted resource for the IPF community by raising awareness, providing disease education, advancing care, and supporting research for IPF whilst defending the interests of IPF patients at European level.
One of the measurements you can track on the patientMpower app is your oxygen saturation(SpO2), which is measured using a pulse oximeter. Not all people using the patientMpower app currently record their oxygen saturation on the platform, and you may therefore be interested to know more about this feature.
This week I had the opportunity to attend the Lung Health Experience hosted by the American College of Chest Physicians (CHEST) in Chicago. This annual event helps spread awareness of asthma, COPD, lung cancer, pulmonary fibrosis and other lung health initiatives.
patientMpower will be exhibiting at ATS 2018 and we would like to invite you to come and visit us to learn more about our specialist remote patient tracking platforms for Pulmonary Fibrosis and Lung Transplant.
Whether you have only been recently diagnosed with pulmonary fibrosis, or have been diagnosed for a while and are starting to experience new symptoms or have recently started new treatments, it can sometimes feel that pulmonary fibrosis is overwhelming.
My name is Kevin Seals. I am 60 years old and live in Bone Gap, IL. I was diagnosed in October of 2012 with Idiopathic Pulmonary Fibrosis (IPF). I first noticed I had constant fatigue, chills, and leg cramps. I was unable to improve my jogging even after working out for six months.
At patientMpower, we’ve evaluated a lot of fingertip pulse oximeters to measure your Oxygen Saturation (SpO2) – an important objective measure for Pulmonary Fibrosis, IPF, and people with any lung disease. Here are our top 3 devices that we’ve tested.